Epilepsy, a neurological disorder, affects millions worldwide. Effective management remains a crucial challenge. Among several treatments, Potiga (ezogabine) offers promising outcomes. Approved by the FDA in 2011, Potiga is unique. It works by targeting potassium channels in the brain. This…
Nevirapine, a non-nucleoside reverse transcriptase inhibitor, plays a vital role in HIV treatment. The nevirapine extended-release tablets offer enhanced pharmacokinetic properties compared to their immediate-release counterparts. This advancement is particularly significant for patient compliance. The once-daily regimen minimizes dose frequency.…